![ECOG-ACRIN logo[19516]275×75](https://blog-ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
December 19, 2025
The trials explore potential treatment improvements for different cancer types: bladder, lung, lymphoma, myeloma, and stomach
November 21, 2025
Timely information about research presented at medical meetings, recognition of research leaders, and more
October 17, 2025
Summaries of two clinical trials presented at the 2025 World Conference on Lung Cancer
September 19, 2025
Timely information about research presented at medical meetings, recognition of research leaders, and more
July 10, 2025
This clinical trial aims to improve survival for high-risk patients by adding a targeted therapy to standard post-surgery immunotherapy
July 10, 2025
The latest clinical trial findings in breast, lung, nose/sinus, and throat cancers, as well as melanoma and cancer survivorship
June 11, 2025
The group is recognizing Dr. Schiller for her sustained commitment to mentoring early- and mid-career investigators in cancer medicine and in ECOG-ACRIN
June 11, 2025
Researchers with the ECOG-ACRIN Cancer Research Group presented a number of research findings at the 2025 ASCO Annual Meeting
April 24, 2025
Summaries of recently published ECOG-ACRIN research results
December 23, 2024
This major new initiative is a unique opportunity for researchers and patients to help build an important real-world data registry of patients with EGFR-mutated non-small cell lung cancer
November 25, 2024
EA5162 is testing a new therapy for certain patients with advanced NSCLC who have developed resistance to other treatments
October 17, 2024
Summaries of recently published ECOG-ACRIN research results